Other specified rheumatoid arthritis affecting a site that does not map to any of the named anatomical locations in the M06.8 subcategory — used when the involved joint or structure is documented but falls outside shoulder, elbow, wrist, hand, hip, knee, ankle/foot, vertebrae, or multiple sites.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- Other
Documentation tips
What should appear in the chart to support M06.8A.
Source · Editorial brief grounded in 6 cited references ↓
- Explicitly name the affected joint or anatomical structure — 'TMJ' or 'sternoclavicular joint,' for example — so reviewers can confirm no site-specific M06.8x code exists for that location.
- Document rheumatoid factor (RF) and anti-CCP serology results; a positive RF may redirect coding to a seropositive M05 code rather than M06.8A.
- Record the RA variant or subtype (e.g., seronegative, overlap syndrome, other specified form) that justifies the 'other specified' designation over M06.9.
- If interstitial lung disease is present, document the RA as the underlying condition so the coder can apply the required 'Code first' sequencing with J84.17x.
- Include disease activity level or clinical scoring (e.g., CDAI, DAS28) and current DMARD or biologic therapy — supports medical necessity for advanced treatments and audits.
Related CPT procedures
Procedure codes commonly billed with M06.8A. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M06.8A and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M06.8A when a named site-specific code exists: if the joint is shoulder, elbow, wrist, hand, hip, knee, ankle/foot, or vertebrae, the correct code is M06.81–M06.88, not M06.8A.
- Defaulting to M06.9 (unspecified) when the provider has named both the RA type and the affected site — M06.8A is the billable, specific code that payers expect when documentation supports it.
- Ignoring serology: a seropositive patient with RA at an 'other specified' site should be evaluated against M05 codes before assigning M06.8A, which lives under M06 (Other rheumatoid arthritis, generally seronegative or unspecified serology).
- Failing to sequence correctly when RA-associated interstitial lung disease is present — M06.8A must be coded as secondary after the J84.17x lung disease code per Tabular List instructions.
- Conflating M06.8A with M06.89 (multiple sites): M06.8A is for a single, documentable site that has no dedicated subcategory code; M06.89 applies when multiple distinct sites are involved.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
M06.8A captures other specified rheumatoid arthritis at an anatomical site that has no dedicated code within the M06.8 series. The prime real-world use case is temporomandibular joint (TMJ) involvement in RA — the code was added in FY2021 specifically to accommodate joints like the TMJ that lacked a site-specific home elsewhere in the subcategory. If the affected site is the shoulder, elbow, wrist, hand, hip, knee, ankle/foot, or vertebrae, those site-specific codes (M06.81–M06.88) apply instead.
M06.8A sits under parent M06.8 (Other specified rheumatoid arthritis), which itself sits under M06 (Other rheumatoid arthritis). 'Other specified' in this context means the RA type does not fall under seropositive RA (M05), seronegative RA (M06.0), adult-onset Still's disease (M06.1), rheumatoid bursitis (M06.2), rheumatoid nodule (M06.3), or inflammatory polyarthropathy (M06.4). Document the specific RA variant and the exact joint or structure involved to justify M06.8A over the unspecified fallback M06.80 or the catch-all M06.9.
When RA causes interstitial lung disease, code the lung condition first (e.g., J84.170 or J84.178) with M06.8A as a secondary code per the 'Code first underlying disease' instruction in the Tabular List. Confirm serology status in the chart: if the patient is seropositive, evaluate whether an M05 code is more precise before landing on M06.8A.
Sibling codes
Other billable codes under M06.8 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01When was M06.8A added to ICD-10-CM?
02Is M06.8A appropriate for temporomandibular joint RA?
03What is the difference between M06.8A and M06.80?
04Can M06.8A be used for a seropositive RA patient?
05How should M06.8A be sequenced when the patient also has RA-associated interstitial lung disease?
06Should I use M06.8A or M06.89 when multiple atypical joints are affected?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M06-/M06.8A
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M06.8A
- 04archive.cdc.govhttps://archive.cdc.gov/www_cdc_gov/nchs/data/icd/Topic-packet-March-2019-Part-1.pdf
- 05unboundmedicine.comhttps://www.unboundmedicine.com/icd/view/ICD-10-CM/1429073/all/M06_8A___Other_specified_rheumatoid_arthritis__other_specified_site
- 06rheumatologyadvisor.comhttps://www.rheumatologyadvisor.com/diagnostic-update/rheumatology-icd-10-codes/
Mira AI Scribe
Mira AI Scribe captures the specific joint name (e.g., temporomandibular, sternoclavicular), RF and anti-CCP lab values, current biologic or DMARD regimen, and any imaging or clinical findings confirming inflammatory arthropathy at that site. That documentation prevents a downcode to M06.9 (unspecified) and closes the audit gap that arises when 'other specified' is claimed without an identified site.
See how Mira captures M06.8A documentation